Specialties
Cartilage
Specialties
Orthopaedics
73 results found in 3ms
ChondroFiller Injection Evidence Patients Should WeighChondroFiller Injection Evidence Patients Should Weigh
Injected collagen scaffold improves focal cartilage defects by 30 IKDC points — exceeding the minimum clinically important difference — sustaining benefit 2–5 years, though only in joints without advanced osteoarthritis; evidence is limited to small cohorts without a large randomised controlled trial.Injected collagen scaffold improves focal cartilage defects by 30 IKDC points — exceeding the minimum clinically important difference — sustaining benefit 2–5 years, though only in joints without advanced osteoarthritis; evidence is limited to small cohorts without a large randomised controlled trial.
ChondroFiller injection versus cartilage surgeryChondroFiller injection versus cartilage surgery
ChondroFiller injection achieves 30 IKDC improvement with 3–8% reoperation and 0% complications; microfracture carries 41% reoperation rates with declining long-term outcomes; ACI/MACI matches functional gains but brings 17% complications and 37% reoperation.ChondroFiller injection achieves 30 IKDC improvement with 3–8% reoperation and 0% complications; microfracture carries 41% reoperation rates with declining long-term outcomes; ACI/MACI matches functional gains but brings 17% complications and 37% reoperation.
Who qualifies for ChondroFiller Liquid Cartilage injectionWho qualifies for ChondroFiller Liquid Cartilage injection
ChondroFiller is an outpatient ultrasound-guided injection—not surgery—of acellular collagen that recruits the patient's own progenitor cells to regenerate cartilage damage, without upper age or defect-size limits.ChondroFiller is an outpatient ultrasound-guided injection—not surgery—of acellular collagen that recruits the patient's own progenitor cells to regenerate cartilage damage, without upper age or defect-size limits.
73 results found in 3ms